Vol 15, No 1 (February 28, 2026): Chinese Clinical Oncology

The present and the future of urological management of prostate cancer

Analysis of the clinical features and surgical treatment of small intestinal stromal tumor: a retrospective study based on 119 cases

Development and validation of a diagnostic model based on artificial intelligence for diagnosing pancreatic cancer

Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study

Microsurgery of a rare case of abducens schwannoma: surgical techniques

Protocol for the impact of medication therapy management on efficacy and safety of postoperative anticoagulation therapy in patients with colorectal cancer: an open-label, prospective and randomized clinical trial

Peri-operative radiotherapy for pancreatic ductal adenocarcinoma: current evidence and future directions: a narrative review

Epidemiology, biomarkers, and therapeutic approach in early- stage biliary tract cancers

Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review

Advances in percutaneous lung ablation: techniques, outcomes, and future directions—a literature review

Advancing the frontiers of hepatocellular carcinoma treatment: a comprehensive review of past, ongoing, and future clinical trials

The evolution of bispecific antibodies in multiple myeloma

Treatment of metastatic pancreatic cancer with concurrent BRAF V600E mutation and germline BRCA2 mutation: a case report

CAR T cells in chronic lymphocytic leukemia: a long unusual journey?

First-line zolbetuximab plus mFOLFOX6 in claudin-18 isoform 2-positive gastric and gastroesophageal junction adenocarcinoma: positioning SPOTLIGHT in the immunotherapy era

The phase III MECCA study on metronomic chemo-endocrine therapy in advanced breast cancer—the results that so many have been waiting for

Preventing unplanned “whoops” sarcoma surgery: from technical pearls to early referral and network-level quality metrics

Endocrine therapy in estrogen receptor-low breast cancer: new evidence, persistent questions

Cadonilimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a step forward for bispecific immunotherapy?

Bispecific immune-angiogenic blockade in extensive-stage small-cell lung cancer—positioning ivonescimab

Patient-reported outcomes in TALAPRO-2 trial: addressing data integrity and comparative clinical benefit in mCRPC